65th Western Intermountain Neurological Organization (WINO) Conference
65th Western Intermountain Neurological Organization (WINO) Conference
65th WINO Conference
Registration is Open
Friday, March 6, 2026
University Marriott Park Hotel
480 Wakara Way, Salt Lake City, UT 84108
KEYNOTE SPEAKERS
Sean Savitz, MD
University of Texas Health Sciences Center
Sean I. Savitz, MD is a Professor of Neurology, the Frank M. Yatsu Chair, Director of the Institute for Stroke and Cerebrovascular Disease at The University of Texas Health Science Center at Houston (UTHealth) and a part of UTHealth Neurosciences. He graduated from Harvard College, received his MD from Albert Einstein College of Medicine, and completed neurology residency training and a cerebrovascular fellowship at the Harvard Medical School Neurology Training Program. Dr. Savitz’s research focuses on stroke recovery, rehabilitation, and the application of stem cells as an innovative treatment for stroke. He has been investigating mechanisms of how cell therapies promote stroke recovery in animal models and he has been conducting clinical trials of autologous and allogeneic cells in stroke patients. He also oversees an NIH funded fellowship program to train stroke specialists and has won several teaching awards. He has been funded by grants from the National Institute of Health, the Howard Hughes Medical Institute, and the American Heart Association, and is an author of over 200 publications in the biomedical literature. As part of his clinical responsibilities, he serves as the stroke medical director the Memorial Hermann Healthcare System.
Eric Smith, MD, MPH
University of Calgary
Dr. Eric Smith is Professor of Neurology, Radiology, and Community Health Sciences at the University of Calgary, and the holder of the endowed Katthy Taylor Chair in Vascular Dementia. He directs the Cognitive Neurosciences Clinic at Foothills Medical Centre and is a member of the Calgary Stroke Program. He is Deputy Editor of the journal Stroke. His research uses neuroimaging and other biomarkers to investigate cerebral small vessel disease and its relationship to stroke and cognitive decline.